Previous Article | Next Article ![]()
Infect Immun, June 1998, p. 2521-2528, Vol. 66, No. 6
Departments of Biological
Sciences,1
Microbiology and Infectious
Diseases,2
Medicine,3 and
Pediatrics,5 University of Calgary,
Calgary, Alberta, Canada T2N 1N4;
Foothills Medical Center,
Calgary, Alberta, Canada T2N 4N14; and
Alberta Children's Hospital, Calgary, Alberta, Canada T2T
5C76
Received 15 December 1997/Returned for modification 30 January
1998/Accepted 7 March 1998
The role of Pseudomonas aeruginosa quorum-sensing
systems in the lung infections associated with cystic fibrosis (CF) has not been examined. The purpose of this study was to determine if genes
regulated by the LasR-LasI quorum-sensing system were coordinately
regulated by the P. aeruginosa populations during the lung
infections associated with CF. We also wanted to ascertain if there was
a relationship between the expression of lasR, a transcriptional regulator, and some P. aeruginosa virulence
factors during these infections. We extracted RNAs from the bacterial populations of 131 sputa taken from 23 CF patients. These RNAs were
blotted and hybridized with probes to P. aeruginosa lasA, lasB, and toxA. The hybridization signals from
each probe were ranked, and the rankings were analyzed by a Spearman
rank correlation to determine if there was an association between the
population transcript accumulations for the three genes. The
correlations between the transcript accumulation patterns of pairs of
the genes suggested that lasA, lasB, and
toxA might be coordinately regulated during CF lung
infections. To determine if this coordinate regulation might be due to
regulation by LasR, we probed RNAs, extracted from 84 sputa, with the
lasR, lasA, lasB, toxA,
and algD probes. Statistical analysis indicated that
lasR transcript accumulation correlated to
lasA, lasB, toxA, and
algD transcript accumulations. These results indicated that
lasR may at least partially regulate or be coordinately
regulated with lasA, lasB, toxA,
and algD during the lung infections associated with CF.
These results also suggested that the LasR-LasI quorum-sensing system
may control the expression of at least some virulence factors in the
lungs of patients with CF.
A number of Pseudomonas
aeruginosa virulence factors are regulated by two quorum-sensing
systems (13, 29, 30, 33-36, 49). One of these sensing
systems, the LasR-LasI system, controls the expression of
lasA, lasB, apr, and toxA
(14, 33, 48). The other system, RhlR-RhlI, controls
lasB, lasA, rhlAB, rpoS, and potentially other genes (3, 22, 23, 29, 30). These two
systems also interact to control the overall regulation of both systems
and their target genes (36). The process of autoinduction in
P. aeruginosa and the other bacterial systems that display this type of regulation was reviewed by Fuqua et al. (12).
Their model suggests that when the bacterial density is low, the
concentration of autoinducer is also low. As the bacterial numbers
increase and if the bacteria are in a closed environment, the
concentration of autoinducer will rise. At a critical level (the
Kd for receptor binding) the autoinducer will
bind the transcriptional activator and trigger the expression of a
number of genes (12). In the case of the LasR-LasI system,
LasR and autoinducer (PAI-1) increase the production of the autoinducer
synthase (lasI product) and expression of the autoinducer
(33, 42). Thus, once the critical concentration of
autoinducer is reached, the level of induction remains high until the
system is shut off in some manner.
A number of quorum-sensing regulatory systems are involved in or are
speculated to be involved in interactions between bacteria and
eucaryotic host organisms (12). Bacteria with quorum-sensing systems that may undergo pathogenic interactions with eucaryotic hosts
are P. aeruginosa (13, 14, 33, 34),
Erwinia spp. (1, 2, 4, 5, 20, 25, 37), and
Agrobacterium tumefaciens (11, 18, 51). Bacteria
with symbiotic relationships with eucaryotic hosts include Vibrio
fischeri and Rhizobium leguminosarum (6-8, 16,
41). Potentially, the common environmental feature of these
interactions is a space barrier that limits the growth of the bacteria
and blocks diffusion of the autoinducer molecules.
The role of the P. aeruginosa quorum-sensing systems in
infectious processes has not been extensively studied. One study
revealed that a lasR mutant, PAOR1 (13), is
significantly less virulent in a neonatal mouse model of infection
(47). The regulatory role of the autoinducer was not
specifically examined in this research, and the authors speculated that
the lasR mutant was deficient in virulence because of a
decrease in neuraminidase expression (47). To date no
studies have been done to determine if P. aeruginosa
quorum-sensing systems are active in human infections. The purpose of
our research was to determine if the P. aeruginosa quorum-sensing systems are functional in the chronic lung infections associated with cystic fibrosis (CF).
The lung infections associated with CF should provide the perfect
environment for control by a quorum-sensing system. The infections are
localized to the airways of the lungs and so are spatially limited. The
bacteria grow to a high density in the lungs (concentrations of
107 to 108 bacteria/ml in sputa are common)
(43, 46), and the bacteria seem to grow in microcolonies or
biofilms. These densities of bacteria should produce concentrations of
autoinducer that would trigger the expression of the target genes.
Furthermore, three genes that are regulated by the LasR-LasI-PAI-1
regulatory system, lasA, toxA, and
lasB (13, 14, 33), are transcribed (38, 45,
46) and expressed (15, 17, 19, 21, 28) in the lungs of
patients with CF. Thus, two questions arose which we wanted to address
in this study. First, is there a correlation between the expressions of
lasB, lasA, and toxA in the lungs of patients with CF? Second, is there a correlation between the
transcriptions of lasR and the various virulence factors in
the P. aeruginosa lung infections associated with CF?
In the present study we found a statistically significant correlation
between the expressions of lasB, lasA, and
toxA in the lungs of patients with CF. This correlation
suggested that these three genes might be at least partially
coordinately regulated in these lung infections. We also found a
correlation between lasR transcript accumulation and
lasA, lasB, and toxA transcript accumulations. Interestingly, there is also a statistically significant correlation between lasR and algD transcript
accumulations. These results suggested that lasR may at
least partially regulate or be coordinately regulated with
lasA, lasB, toxA, and perhaps
algD.
Patient population.
Two overlapping groups of patients were
used in this study. The first group was identical to the patients
selected for a previous study described by Storey et al.
(45). This was a group of 23 patients with CF. Of these
patients, 13 were female and 10 were male. The median age for these
patients was 15.5 years at the beginning of the study. A subset of 16 patients was also used in the analysis for this study. These patients
were all from the Alberta Children's Hospital Cystic Fibrosis Clinic.
Of these patients, seven were female and nine were male. The age range
of the patients at the beginning of the study was 10 to 19 years, with
a median age of 13 years. All patients and their guardians gave their
voluntary consent to participate in this study. The study design was
given ethical review and approval by the Conjoint Research Ethics Board at the University of Calgary. Selection of the patients was carried out
to ensure that equal numbers of patients would have mild, moderate, or
severe pulmonary disease. Patients with a forced expiratory volume in 1 s (FEV1) of <40% of predicted values were considered to be in the
severe category of disease. A patient FEV1 in the range of >40% but
<70% of predicted values was considered to be in the moderate range
of pulmonary disease. The mild category of disease severity consisted
of those patients with an FEV1 of >70% of predicted values.
Sputum collection and storage and extraction of total RNA.
At each clinic visit sputum was collected from each patient in the
study. The samples were diluted with Sputalysin (Calbiochem-Behring, Horescht)-H2O and divided into two parts. One part was
frozen at DNA probes.
A 550-bp PstI fragment from pMJG1.7
was used to hybridize to lasR-specific mRNAs. Plasmid
pMJG1.7 was a generous gift from B. H. Iglewski (13).
The probes used for lasA, lasB, toxA,
and algD mRNAs have been described previously
(45).
Growth conditions and extraction of control RNA.
Control
RNAs (algD, lasA, lasB,
lasR, and toxA) were included on each blot to
normalize the results from different blots and hybridizations.
Preparation of the control RNAs for algD, lasA, lasB, and toxA has been previously described
(45). Control RNA for lasR was extracted from
P. aeruginosa PAO1 grown in peptone Trypticase soy broth
(32) to an optical density at 540 nm of 4.0. RNA was
extracted from 2 × 108 cells, as previously described
(9, 10).
Determination of lasR mRNA half-life.
The
half-life of lasR mRNA was determined by using a culture of
P. aeruginosa PAO1 grown in peptone Trypticase soy broth
(32) to an optical density at 540 nm of 4.0. Rifampin was
added to the culture at a concentration of 200 µg/ml, and an aliquot
of the culture was removed. RNA was extracted from the aliquot as previously described (9). Additional aliquots were removed from the culture at 2.5-min intervals. As each aliquot was removed, the
RNA was immediately extracted. The RNA from each time point was then
electrophoresed on a glyoxal gel, blotted onto Nytran (Schleicher and
Schuell), probed, autoradiographed, and scanned for signal intensity
(46).
Statistical analysis.
Correlations between the groups of
hybridizations were analyzed by using the Spearman rank correlation
(50). For comparison, the results from each sample were
ranked on the level of hybridization with each probe. The subprogram
Rank from Minitab was used to generate these ranks (40). To
generate a Spearman rank correlation, the ranks from two probes were
subtracted from each other and the difference was squared. The squares
were then summed and used to calculate a Spearman rank correlation
coefficient (rs) (50). As in the
study described by Storey et al. (45), we initially analyzed
151 sputa that contained RNA based on a measurement of optical density
at 260 nm. In 20 of these samples we were unable to detect any
hybridization with our probes. Thus, we excluded these 20 samples from
the analysis presented in this paper.
Correlation between toxA, lasB, and
lasA transcript accumulations.
Recently our laboratory
has shown correlations between the population transcript accumulation
for algD and that for either lasA or
lasB. In the present study we wanted to address the
possibility of an association between lasA, lasB,
and toxA transcript accumulations. To determine if there
were correlations between the transcript accumulations for the three
virulence determinants, we probed 131 RNA samples extracted directly
from the sputa of 23 patients. Table 1
shows the Spearman rank correlation coefficients for these comparisons,
and Fig. 1 shows the direct comparisons.
Interestingly, there were statistically significant correlations
between lasA and lasB, lasB and
toxA, and lasA and toxA. The highest
correlation was between lasA and lasB (Table 1;
Fig. 1A), followed closely by the correlation between lasB
and toxA (Table 1; Fig. 1B). The lowest correlation was
between lasA and toxA (Table 1; Fig. 1C). These
results suggested that during the lung infections associated with CF,
P. aeruginosa populations coordinated the regulation of
these three virulence factors. The two most likely explanations for
these correlations are that the genes are responding to a common
environmental cue or to a common regulatory protein. In a clonal
situation all three genes have been shown to be regulated by LasR
(14, 48). Thus, a common regulatory gene that might coordinately regulate these three genes in the lungs of CF patients is
lasR. It therefore was of interest to determine if
lasR population transcript accumulation corresponded to the
population transcript accumulations for lasA,
lasB, and toxA.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Pseudomonas aeruginosa lasR
Transcription Correlates with the Transcription of lasA,
lasB, and toxA in Chronic Lung Infections
Associated with Cystic Fibrosis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
70°C for later extraction of the total RNA. The second
part was used to determine the number and types of bacteria present in
the sputum. Extraction of total RNA from the sputa, slot blots of the
RNA, hybridization, autoradiography, and measurement of the sample
intensity were all performed as previously described (46).
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
TABLE 1.
Statistical analysis of the associations between the
population transcript accumulations for lasA,
lasB, toxA, lasR, and algD
during the chronic lung infections associated with CF

View larger version (25K):
[in a new window]
FIG. 1.
Scatter plots for the population transcript
accumulations for lasA, lasB, and
toxA. In these plots the results for 131 sputum samples are
presented. For each sample, 10 µg of the total RNA extracted from the
pelleted bacterial population was blotted onto a Nytran membrane
(Schleicher and Schuell) and hybridized with the toxA probe.
The blots were then washed to remove the probe, and the membrane was
rehybridized with the lasB probe. The process was repeated
with the lasA probe. The relative intensity for the sample
was measured from the autoradiograph with a soft laser scanning
densitometer. The results represent 10 µg of RNA from equivalent
numbers of cells. (A and B) Comparison of lasB population
transcript accumulation to lasA (A) and toxA (B)
population transcript accumulations. The results were sorted to
generate a linear plot for the lasB hybridizations. The
solid lines represent the sorted results. The dashed lines represent
the trend line for lasA or toxA. (C) Comparison
of lasA population transcript accumulation to
toxA population transcript accumulation. The results were
sorted to generate a linear plot for the lasA. The solid
line represents the sorted results. The dashed line represents the
trend line for toxA.
Determination of the half-life of lasR mRNA. To determine if we could compare the transcript accumulations for the genes of interest, we determined the half-life of lasR. For P. aeruginosa PAO1 we found that the half-life of lasR mRNA was 2 min (44a). Thus, it appears that lasR mRNA has a considerably shorter half-life than toxA (10 min [24]), lasA (8.5 min [45]), and lasB (11 min [46]) mRNAs. The difference in mRNA half-lives between the transcripts suggested that we might have difficulty detecting a loose association between the genes because of the rapid degradation of the transcripts.
Comparison of transcript accumulations in an individual patient with CF. To determine if there was a correlation between the various virulence factors and lasR transcript accumulation, we monitored a number of patients over a 3- to 5-year period. We have also included in our study the algD probe, because transcript accumulation for this gene has recently been shown to correlate with lasA and lasB transcript accumulations in the lung infections associated with CF (45).
Figure 2 shows the results from one such patient (patient 15) over a period of about 1 year. In all but one sample the concentration of P. aeruginosa was
108 bacteria/ml of sputum. The one exception was the
sample taken at the beginning of the study, on 28 October (5 × 106 bacteria/ml of sputum). These concentrations should be
high enough to trigger the quorum-sensing regulation in P. aeruginosa. Figure 2 shows that lasR transcript
accumulation seems to correspond to the transcript accumulations for
all four other genes. In particular, in the last eight samples
lasR transcript accumulation corresponded fairly tightly to
toxA, lasB, lasA, and algD
population transcript accumulations, whereas the first three samples
showed less correlation between lasR population transcript
accumulation and those for four other genes (Fig. 2). Overall, the
results from this patient suggested that a correlation might exist
between lasR and some of virulence factors produced by
P. aeruginosa in the lungs of patients with CF. Thus, we
wanted to analyze a larger number of samples from a number of CF
patients at various stages of their disease.
|
Comparison of P. aeruginosa lasR population transcript accumulation to lasA, lasB, toxA, and algD population transcript accumulations. To take a systematic approach to the question of whether lasR transcript accumulation correlates to those for lasA, lasB, toxA, and algD, we probed 84 RNA samples extracted from the sputa from 16 pediatric CF patients. Table 1 shows the Spearman rank correlation coefficients for these comparisons. The highest correlation was between lasR and lasA (Table 1; Fig. 3A), followed by lasR and lasB (Table 1; Fig. 3B). The third best correlation was between lasR and toxA (Table 1; Fig. 3C). The weakest correlation was between lasR and algD (Table 1; Fig. 3). These results suggested that lasR might regulate or be coordinately regulated with lasA, lasB, and toxA. Furthermore, the relationship between lasR transcript accumulation and algD transcript accumulation might indicate a partial regulation of algD by lasR or a common environmental cue triggering the two genes.
|
Potential cross-reaction between lasR and lasR-like genes from other organisms in the sputa. Quorum-sensing mechanisms are found in numerous microorganisms. In particular, gram-negative bacteria utilize these systems to control numerous processes (12). In our study, 58% of the sputa collected contained at least one other pathogenic organism (Table 2). However, Table 2 also shows that in the majority of samples with other pathogenic organisms, P. aeruginosa was the predominant organism. Overall, in 75% of all the sputa analyzed, P. aeruginosa was the predominant organism by at least 100-fold. Nonetheless, a possible interfering factor in our analysis might be cross-reactivity of our probes with the mRNAs from other organisms. This was particularly a problem with lasR, because lasR or luxR homologs have been found in numerous organisms (12). To specifically address this problem, we segregated the 35 sputum samples that contained P. aeruginosa and no other pathogenic organisms and reanalyzed the results. Table 1 shows that for lasR-lasA, lasR-lasB, and lasR-toxA comparisons we still achieved strong, statistically significant correlations between the transcript accumulation patterns of these genes with the 35 sputum samples. For the comparison of lasR to algD, we also achieved a statistically significant correlation between the transcript accumulations for these genes, but the correlation was not as strong. Thus, in our analysis it did not seem to matter whether we used the total number of samples with P. aeruginosa as the predominant organism or samples with P. aeruginosa as the only pathogenic organism. Overall, this comparison suggested that cross-reactivity with our probes and the mRNAs from other microbes was not a significant factor in our analysis.
|
| |
DISCUSSION |
|---|
|
|
|---|
Traditionally, analysis of coordinate regulation involves the deletion of the regulatory gene and an analysis of the mutant bacterium growing under laboratory conditions. Commonly, a single environmental cue is used to trigger the coordinate expression (26, 27). To establish the role of coordinate regulation in the pathogenicity of an organism, a regulatory mutant is usually tested in comparison to a wild-type strain in an inbred animal model. The situation with the chronic P. aeruginosa lung infections in CF patients is more complex. CF affects a wide range of individuals with different genetic backgrounds, who present with different clinical manifestations of their disease (52). The infections tend to involve numerous strains of P. aeruginosa with potentially different phenotypes (31, 39, 44). Finally, over time the patients have exacerbations of their respiratory symptoms. Our approach to the analysis of regulation in the lung infections associated with CF has been to look for correlations between the transcript accumulations for various genes in the bacterial populations found in the sputum taken directly from the patient. Thus, we are examining the organisms actually causing the infection rather than a single isolate introduced into an animal model. One difficulty with our approach is that different populations of bacteria in the sputum may be expressing different sets of genes at the same time. This may bias the results, because independently expressed genes may appear to correlate with each other or genes which are coordinately regulated may not appear to correlate. To partially minimize this problem, we have taken a large number of samples from a diverse set of patients over a fairly lengthy period of time. This ensured that we were sampling a diverse set of organisms exposed to a variety of environmental cues. Once the transcript accumulation has been measured for each sample, we then rank the results for each probe. The rankings are then compared for two probes with the Spearman rank correlation (50). For a statistically significant correlation to result, there has to be close association of the rankings across all the samples. For this approach to result in a false correlation, various subpopulations of bacteria would have to be expressing different genes at various levels across a wide range of patients and environmental conditions. A more likely scenario is that of a false null correlation in which the various subpopulations confuse the results by expressing different genes at different times. Thus, one might expect that we would have difficulties finding correlations between expression of genes even if they were regulated by the same transcriptional activator. However, in the current study and in past studies (38, 45) we have found statistically significant correlations between the transcript accumulations for various genes. These correlations occurred even with large sample sizes from a diverse set of patients (Table 1) (45). While these correlations do not exclude the possibility that subpopulations of bacteria may be expressing different genes, they do suggest that some process is coordinating the expression across the bacterial populations found in sputum.
A number of the quorum-sensing systems regulate genes involved with interactions between bacterial populations and their eucaryotic hosts (12). However, it has not been established that the quorum-sensing systems of P. aeruginosa are important in interactions with eucaryotic hosts. In particular, it has not been established that either of the quorum-sensing systems (LasR-LasI or RhlR-RhlI) regulates virulence factors during human infections. As a first step in determining the importance of the P. aeruginosa LasR-LasI quorum-sensing system in the lung infections associated with CF, we wanted to determine if there was a coordinated expression of some of the virulence factors that might be controlled by the LasR-LasI regulatory system. Additionally, we wanted to determine if there was a correlation of those virulence factors with lasR expression.
We speculated that the quorum-sensing systems of P. aeruginosa may play a role in the chronic lung infections associated with CF for a number of reasons. In these infections P. aeruginosa grows to a high bacterial density (43, 46) and is spatially limited by the lung environment. Both of these factors are critical to the triggering of quorum sensing in many diverse systems (12). Another reason we suspect that quorum sensing might play a role in these infections is the detection of lasA, lasB, and toxA transcript accumulation in the bacterial populations found in CF sputa (45). When P. aeruginosa is grown in the laboratory, it appears that lasA and lasB are tightly regulated by the LasR-LasI quorum-sensing system (14, 33) and that toxA transcription is modulated by the system (48). Therefore, if toxA, lasB, and lasA are coordinately regulated in the lung infections associated with CF, then a correlation might exist for the transcript accumulation patterns of these three genes. Indeed, Table 1 and Fig. 1 revealed a correlation of the transcript accumulations for the three genes during the chronic lung infections associated with CF. The strongest correlation was between lasA and lasB (Spearman rank correlation, n = 131, rs = 0.595, P < 0.001), followed by lasB and toxA (n = 131, rs = 0.570, P < 0.001) and lasA and toxA (n = 131, rs = 0.423, P < 0.001) (Table 1). The most likely explanations for these correlations are that in the lungs of CF patients, these genes might be coordinately regulated or might be responding to a common environmental cue.
In light of previous work showing that in a clonal situation lasA, lasB, and to some extent toxA were controlled by a common regulatory element, lasR (14, 33, 48), we decided to probe our RNA samples with a lasR-specific probe. The results from an individual patient (Fig. 2), as well as the results from numerous patients (Table 1; Fig. 3), revealed that lasR transcript accumulation correlated with lasA, lasB, and toxA transcript accumulations. A potential problem with our probes could be cross-reactivity with the mRNAs from other organisms found in the sputum. This is particularly a problem with the lasR probe, as lasR and luxR homologs have been found in a number of pathogenic organisms (12). To alleviate this problem, we segregated 35 of our sputum samples that contained only P. aeruginosa and no other pathogenic organism and reevaluated our data. Table 1 shows that the same correlations existed for the 35 samples with only P. aeruginosa as the pathogenic organism as for the sputa containing P. aeruginosa and at least one other pathogen. These results suggested that our probes were specific for the targeted genes.
Our results are the first to implicate LasR as a transcriptional activator in a human infection and to suggest that it might control multiple virulence factors in these infections. Furthermore, since lasR must be activated by PAI in order to transcribe lasA and lasB (14, 33), our results suggested that the LasR-LasI-PAI-1 autoinduction system was active in the lung infections associated with CF.
The significant but not perfect correlation between lasR, lasA, and lasB population transcript accumulations suggested that other regulatory systems might also be active in the lung environment. One possibility is the RhlR-RhlI-PAI-2 system, which has also been shown to influence the regulation of all three of these genes (3, 36, 49) and to interact with the LasR-LasI-PAI-1 system. Thus, one might speculate that a combination of control by the RhlR-RhlI and the LasR-LasI systems could account for our results. We are currently studying the role that the RhlR-RhlI system has in the regulation of P. aeruginosa virulence factors in the chronic lung infections associated with CF.
A curious finding of this study is the statistically significant correlation (n = 84, rs = 0.309, P < 0.01; n = 35, rs = 0.350, P < 0.05) of lasR population transcript accumulation to algD population transcript accumulation. While this association may not be particularly strong, it fits with a previous finding that in the lung infections associated with CF, algD population transcript accumulation correlates with lasA and lasB transcript accumulations (45). The correlation between lasR and algD could be explained in a number of ways. First, lasR may directly modulate expression of algD. Notably, there is a putative lasR box upstream of the algD promoter that matches the lasR box upstream of lasB at 9 of 20 nucleotides, which could possibly serve as a binding site. Second, one of the regulators of algD could be regulated by lasR, thus accounting for the partial correlation between lasR and algD. A third possibility is that a common environmental cue may control both systems and that this accounts for the correlation of population transcript accumulation between the two genes. A final explanation is that algD mRNA has the longest half-life of the transcripts and so by its longevity (45) and circumstances correlates to lasR transcript accumulation. This last explanation is not likely the case, because one would then expect to see a low level of correlation between algD and all the other transcripts which have longer half-lives than lasR. However, we previously reported that there was not a statistically significant association between algD and toxA (45). Thus, it is not likely that the correlation between lasR and algD population transcript accumulations occurs by chance.
The correlation of lasR population transcript accumulation to toxA transcript accumulation (Table 1) is also curious in light of the previous finding that there is a strong association between expression of the regAB operon and toxA in the lungs of patients with CF (38). In P. aeruginosa PAO1, LasR has been shown to enhance toxA transcription (48). However, this evidently does not occur by enhancement of regA transcription (48). At least some isolates from CF patients appear to regulate toxA in a manner different from that of strain PAO1 and similar to that of strain PA103 (38). Strain PA103 has a gene, regB, that appears to enhance activity from the P1 promoter of the regAB operon. Strain PAO1 lacks regB; thus, it is possible that LasR and RegB interact to promote expression of the P1 promoter and cause a high level of expression of toxA in strains from CF patients. Another possibility is that in isolates from CF patients, LasR may control toxA regulation by interacting with the regAB operon. A third possibility is that LasR may only partially regulate toxA expression and that regA is needed for full control of toxA expression. Further work will be needed to test these possibilities.
In summary, we revealed a correlation between lasA, lasB, and toxA population transcript accumulations that might suggest a coordinated regulation of these genes during the chronic lung infections associated with CF. We also detected lasR population transcript accumulation in the bacterial populations found in sputa. Furthermore, we found a correlation between lasR population transcript accumulation and those for four P. aeruginosa virulence genes. Thus, in the chronic lung infections associated with CF, lasR may at least partially regulate the virulence genes lasA, lasB, and toxA. This finding may indicate that the LasR-LasI quorum-sensing system may be active in these infections. Our results also suggested that lasR may either partially regulate algD or respond to the same environmental cues as algD.
| |
ACKNOWLEDGMENTS |
|---|
We thank B. H. Iglewski for the generous gift of plasmids pMJG1.7, containing the lasR clone, and pPS1816, containing the lasA clone. We also thank D. E. Ohman for plasmid pCC27, containing the algD clone. Thanks are due to K. Jamieson for her organization of the patient results and K. E. Sanderson and H. Ceri for critically reading the manuscript. We are indebted to the patients who participated in this study.
This study was supported by the RDP II of the Canadian Cystic Fibrosis Foundation and a grant to D.G.S. from the Canadian Cystic Fibrosis Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biological Sciences, Faculty of Science, The University of Calgary, 2500 University Dr., N.W., Calgary, Alberta, Canada T2N 1N4. Phone: (403) 220-5274. Fax: (403) 289-9311. E-mail: storey{at}acs.ucalgary.ca.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bainton, N. J., B. W. Bycroft, S. R. Chabra, P. Stead, L. Geldhill, P. J. Hill, C. E. Rees, M. K. Winson, G. P. Salmond, G. S. A. B. Stewart, and P. Williams. 1992. A general role for the lux autoinducer in bacterial cell signalling: control of antibiotic synthesis in Erwinia. Gene 116:87-91[Medline]. |
| 2. |
Beck von Bodman, S., and S. Farrand.
1995.
Capsular polysaccharide biosynthesis and pathogenicity in Erwinia stewartii require induction by an N-acylhomoserine lactone autoinducer.
J. Bacteriol.
177:5000-5008 |
| 3. |
Brint, J. M., and D. E. Ohman.
1996.
Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RHLR-RHLI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family.
J. Bacteriol.
177:7155-7163 |
| 4. | Chatterjee, A., Y. Cui, Y. Lui, C. K. Dumenyo, and A. K. Chatterjee. 1995. Inactivation of rsmA leads to overproduction of extracellular pectinases, cellulases, and proteases in Erwinia carotovora subsp. carotovora in the absence of the starvation/cell density-sensing signal, N-(3-oxohexanoyl)-L-homoserine lactone. Appl. Environ. Microbiol. 61:1959-1967[Abstract]. |
| 5. |
Cui, Y.,
A. Chatterjee,
Y. Liu,
C. K. Dumenyo, and A. K. Chatterjee.
1995.
Identification of a global repressor gene, rsmA, of Erwinia carotovora subsp. carotovora that controls extracellular enzymes, N-(3-oxohexanoyl)-L-homoserine lactone, and pathogenicity in soft-rotting Erwinia spp.
J. Bacteriol.
177:5108-5115 |
| 6. | Eberhard, A., A. L. Burlingame, C. Eberhard, G. K. Kenyon, K. H. Nealson, and N. J. Oppenheimer. 1981. Structural identification of autoinducer of Photobacterium fischeri. Biochemistry 20:2444-2449[Medline]. |
| 7. | Engebrecht, J., K. Nealson, and M. Silverman. 1983. Bacterial bioluminescence: isolation and genetic analysis of functions from Vibrio fischeri. Cell 32:773-781[Medline]. |
| 8. |
Engebrecht, J., and M. Silverman.
1984.
Identification of genes and gene products necessary for bacterial bioluminescence.
Proc. Natl. Acad. Sci. USA
81:4154-4158 |
| 9. |
Frank, D. W., and B. H. Iglewski.
1988.
Kinetics of toxA and regA mRNA accumulation in Pseudomonas aeruginosa.
J. Bacteriol.
170:4477-4483 |
| 10. |
Frank, D. W.,
D. G. Storey,
M. S. Hindahl, and B. H. Iglewski.
1989.
Differential regulation by iron of regA and toxA transcript accumulation in Pseudomonas aeruginosa.
J. Bacteriol.
171:5304-5313 |
| 11. |
Fuqua, W. C., and S. C. Winans.
1994.
A LuxR-LuxI type regulatory system activates Agrobacterium Ti plasmid conjugal transfer in the presence of a plant tumor metabolite.
J. Bacteriol.
176:2796-2806 |
| 12. | Fuqua, W. C., S. C. Winans, and E. P. Greenberg. 1996. Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum sensing transcriptional regulators. Annu. Rev. Microbiol. 50:727-751[Medline]. |
| 13. |
Gambello, M. J., and B. H. Iglewski.
1991.
Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression.
J. Bacteriol.
173:3000-3009 |
| 14. |
Gambello, M. J.,
S. Kaye, and B. H. Iglewski.
1993.
LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression.
Infect. Immun.
61:1180-1184 |
| 15. | Granstrom, M., A. Ericsson, B. Strandvik, B. Wretlind, O. R. Pavlovskis, R. Berka, and M. L. Vasil. 1984. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr. Scand. 73:772-777[Medline]. |
| 16. |
Gray, K. M.,
J. P. Pearson,
J. A. Downie,
B. E. A. Boboye, and E. P. Greenberg.
1996.
Quorum sensing in the symbiotic nitrogen-fixing bacterium Rhizobium leguminosarum: autoinduction of a stationary phase and rhizosphere-expressed genes.
J. Bacteriol.
178:372-376 |
| 17. |
Hollsing, A. E.,
M. Granstrom,
M. L. Vasil,
B. Wretlind, and B. Strandvik.
1987.
Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
J. Clin. Microbiol.
25:1868-1874 |
| 18. |
Hwang, I.,
P. Li,
L. Zhang,
K. R. Piper,
D. M. Cook,
M. E. Tate, and S. K. Farrand.
1994.
TraI, a LuxI homologue, is responsible for production of conjugation factor, the Ti plasmid N-acylhomoserine lactone autoinducer.
Proc. Natl. Acad. Sci. USA
91:4639-4643 |
| 19. |
Jagger, K. S.,
D. L. Robinson,
M. N. Franz, and R. L. Warren.
1982.
Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
J. Clin. Microbiol.
15:1054-1058 |
| 20. | Jones, S., B. Yu, N. J. Bainton, M. Birdsall, B. W. Bycroft, S. R. Chhabra, A. J. Cox, P. Golby, P. J. Reeves, S. Stephens, M. K. Winson, G. P. C. Salmond, G. S. A. B. Stewart, and P. Williams. 1993. The lux autoinducer regulates the production of exoenzyme determinants in Erwinia carotovora and Pseudomonas aeruginosa. EMBO J. 12:2477-2482[Medline]. |
| 21. | Klinger, J. D., D. C. Straus, C. B. Hilton, and J. A. Bass. 1978. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay. J. Infect. Dis. 138:49-58[Medline]. |
| 22. | Latifi, A., M. Foglino, K. Tanaka, P. Williams, and A. Lazdunski. 1996. A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhlR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol. Microbiol. 21:1137-1146[Medline]. |
| 23. | Latifi, A., M. K. Winson, M. Foglino, B. W. Bycroft, G. S. A. B. Stewart, A. Lazdunski, and P. Williams. 1995. Multiple homologues of LuxR and Luxl control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 17:333-343[Medline]. |
| 24. |
Lory, S.
1986.
Effect of iron on accumulation of exotoxin A-specific mRNA in Pseudomonas aeruginosa.
J. Bacteriol.
168:1451-1456 |
| 25. |
McGowan, S.,
M. Sebaihia,
S. Jones,
B. Yu,
N. Bainton,
Chan,
B. Bycroft,
G. S. Stewart,
P. Williams, and G. P. Salmond.
1995.
Carbapenem antibiotic production in Erwinia carotovora is regulated by CarR, a homologue of the LuxR transcriptional activator.
Microbiology
141:541-550 |
| 26. |
Mekalanos, J. J.
1992.
Environmental signals controlling expression of virulence determinants in bacteria.
J. Bacteriol.
174:1-7 |
| 27. |
Miller, J. F.
1989.
Coordinate regulation and sensory transduction in the control of bacterial virulence.
Science
243:916-922 |
| 28. | Moss, R. B., Y. Hsu, N. J. Lewiston, J. G. Curd, H. Milgrom, S. Hart, B. Dyer, and J. W. Larrick. 1986. Association of systemic immune complexes, complement activation and antibodies to Pseudomonas aeruginosa lipopolysaccharride and exotoxin A with mortality in cystic fibrosis. Am. Rev. Respir. Dis. 133:648-652[Medline]. |
| 29. |
Ochsner, U. A.,
A. Fiechter, and J. Reiser.
1994.
Isolation, characterization, and expression in Escherichia coli of the Pseudomonas aeruginosa rhlAB genes encoding a rhamnosyltransferase involved in rhamnolipid biosurfactant synthesis.
J. Biol. Chem.
269:19787-19795 |
| 30. |
Ochsner, U. A., and J. Reiser.
1995.
Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa.
Proc. Natl. Acad. Sci. USA
92:6424-6428 |
| 31. | Ogle, J. W., J. M. Janda, D. E. Woods, and M. L. Vasil. 1987. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J. Infect. Dis. 155:119-126[Medline]. |
| 32. |
Ohman, D. E.,
S. J. Cryz, and B. H. Iglewski.
1980.
Isolation and characterization of a Pseudomonas aeruginosa PAO mutant that produces altered elastase.
J. Bacteriol.
142:836-842 |
| 33. |
Passador, L.,
J. M. Cook,
M. J. Gambello,
L. Rust, and B. H. Iglewski.
1993.
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication.
Science
260:1127-1130 |
| 34. |
Pearson, J. P.,
K. M. Gray,
L. Passador,
K. D. Tucker,
A. Eberhard,
B. H. Iglewski, and E. P. Greenberg.
1994.
Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.
Proc. Natl. Acad. Sci. USA
91:197-201 |
| 35. |
Pearson, J. P.,
L. Passador,
B. H. Iglewski, and E. P. Greenberg.
1995.
A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa.
Proc. Natl. Acad. Sci. USA
92:1490-1494 |
| 36. |
Pesci, E. C.,
J. P. Pearson,
P. C. Seed, and B. H. Iglewski.
1997.
Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa.
J. Bacteriol.
179:3127-3133 |
| 37. | Pirhonen, M., D. Flego, R. Heikinheimo, and E. T. Palva. 1993. A small diffusible molecule is responsible for the global control of virulence and exoenzyme production in the plant pathogen Erwinia carotovora. EMBO J. 12:2467-2476[Medline]. |
| 38. |
Raivio, T. L.,
E. E. Ujack,
H. R. Rabin, and D. G. Storey.
1994.
Association between transcript levels of the Pseudomonas aeruginosa regA, regB, and toxA genes in sputa of cystic fibrosis patients.
Infect. Immun.
62:3506-3514 |
| 39. | Römling, U., B. Fiedler, J. Bosshammer, D. Grothues, J. Greipel, H. von der Hardt, and B. Tümmler. 1994. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 170:1616-1621[Medline]. |
| 40. | Ryan, B. F., and B. L. Joiner. 1994. In Minitab handbook. Duxbury Press, Belmont, Calif. |
| 41. |
Schripsema, J.,
K. E. E. de Rudder,
T. B. van Vliet,
P. P. Lankhorst,
E. de Vroom, and E. P. Greenberg.
1996.
Bacteriocin small of Rhizobium leguminosarum belongs to the class of N-acyl-homoserine lactone molecules, known as autoinducers and as quorum sensing co-transcription factors.
J. Bacteriol.
178:366-371 |
| 42. |
Seed, P. C.,
L. Passador, and B. H. Iglewski.
1995.
Activation of the Pseudomonas aeruginosa lasI gene by LasR and the Pseudomonas autoinducer PAI: an autoinduction regulatory hierarchy.
J. Bacteriol.
177:654-659 |
| 43. | Smith, A. L., G. Redding, C. Doershuk, D. Goldmann, E. Gore, B. Hilman, M. Marks, R. Moss, B. Ramsey, T. Rubio, R. H. Schwartz, M. J. Thomassen, J. Williams-Warren, A. Weber, R. W. Wilmott, H. D. Wilson, and R. Yogev. 1988. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J. Pediatr. 112:547-554[Medline]. |
| 44. |
Speert, D. P.,
M. E. Campbell,
S. W. Farmer,
K. Volpel,
A. M. Joffe, and W. Paranchych.
1989.
Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.
J. Clin. Microbiol.
27:2589-2593 |
| 44a. | Storey, D. G., and E. E. Ujack. Data not shown. |
| 45. | Storey, D. G., E. E. Ujack, I. Mitchell, and H. R. Rabin. 1997. Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Infect. Immun. 65:4061-4067[Abstract]. |
| 46. |
Storey, D. G.,
E. E. Ujack, and H. R. Rabin.
1992.
Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis.
Infect. Immun.
60:4687-4694 |
| 47. | Tang, H. B., E. DiMango, R. Bryan, M. Gambello, B. H. Iglewski, J. B. Goldberg, and A. Prince. 1996. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64:37-43[Abstract]. |
| 48. | Toder, D. S., M. J. Gambello, and B. H. Iglewski. 1991. Pseudomonas aeruginosa LasA: a second elastase under the transcriptional control of lasR. Mol. Microbiol. 5:2003-2010[Medline]. |
| 49. |
Winson, M. K.,
M. Camara,
A. Latifi,
M. Foglino,
S. R. Chhabra,
M. Daykin,
M. Bally,
V. Chapon,
G. P. Salmond,
B. W. Bycroft,
A. Lazdunski,
G. S. A. B. Stewart, and P. Williams.
1995.
Multiple N-acyl-L-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa.
Proc. Natl. Acad. Sci. USA
92:9427-9431 |
| 50. | Zar, J. H. 1974. Rank correlation, p. 243-245. In W. D. McElroy, and C. P. Swanson (ed.), Biostatistical analysis. Prentice-Hall, Inc., Englewood Cliffs, N.J. |
| 51. | Zhang, L., P. J. Murphy, A. Kerr, and M. E. Tate. 1993. Agrobacterium conjugation and gene regulation by N-acyl-L-homoserine lactones. Nature 362:446-448[Medline]. |
| 52. | Zielenski, J., and L. C. Tsui. 1995. Cystic fibrosis: genotypic and phenotypic variations. Annu. Rev. Genet. 29:777-807[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»